A group of cancer researchers in Mexico has lost their third paper over concerns about the integrity of their data.
Neither the new retraction, in the journal Hematology, nor the previous two, cite misconduct as the reason for the removals. However, the statements do refer to lack of reliability of results, “ambiguities and inconsistencies” in the findings and other serious issues.
The first author on each paper is Agustin Avilés, whom the Hematology article listed as being with the National Medical Center in Mexico City.
The Journal of Clinical Investigation has retracted two papers from the lab of one of Stanford University’s most prominent cancer researchers over concerns about the integrity of the data.
The articles, published in 2012 and 2014, described work on ways of priming the immune system to enhance the activity of drugs to fight cancer.
The first author on the two articles was Holbrook “Brook” Kohrt, a superstar young faculty member who died in 2016 of complications of hemophilia. Kohrt was the subject of this 2013 profile in the New York Times, which also wrote an obituary of him.
Carlo Croce, a professor at The Ohio State University in Columbus who has faced multiple investigations into misconduct allegations, has been denied a temporary restraining order that he sought in order to be reinstated as chair of his department.
Croce was forced to step down from the post last year. Magistrate Jennifer D. Hunt, of the Franklin County civil court, wrote in a January 23 decision that
third parties and the public interest will be harmed if a temporary restraining order is granted and Dr. Croce is reinstated as Chair.
Carlo Croce, the embattled cancer researcher at The Ohio State University (OSU), is suing the institution to reclaim the department chair he lost late last year for reasons that he says are unclear.
In a filing with the Franklin County civil court, Croce and his attorneys, from the Columbus firm of James E. Arnold and Associates, argue that the university failed to follow its own rules for demoting faculty members last year when it stripped Croce of his position of chair of the Department of Cancer Genetics and Biology. Croce had held the post for more than three consecutive four-year terms, starting in October 2004.
A radiology journal has published an addendum to a 2005 review on cancer imaging techniques, alerting readers to figure duplication.
But that’s not what caught our attention about this case. The addendum, published in January, is the third notice that The British Journal of Radiology (BJR) has issued for the 2005 review by Hedvig Hricak, chair of the Department of Radiology at Memorial Sloan Kettering in New York City. The notices, published between 2014 and 2018, all describe duplication.
What Caught Our Attention: The researchers were studying how curcumin, a component of the spice turmeric, can inhibit lung cancer metastases. But upon learning that the primary material had been expired at the time of testing (and realizing they were unable to repeat their experiments), the researchers pulled their paper. Expiration dates do have safety factors built in, but attention to such details is imperative in research. Continue reading Caught Our Notice: What if you find out a paper relied on expired herbal supplement?
What Caught Our Attention: When authors fail to respond to editors’ requests for information, it isn’t hard to imagine that the submitted manuscript will lose its publishing appeal. In this case, the journal and publisher withdrew the article after “repeated attempts” to contact the authors were unsuccessful.
A new journal is offering something we’ve never seen before: A cash reward to corresponding authors of papers it publishes.
Normally, in the case of open-access journals, researchers have to pay article processing charges (APCs). But Minimally Invasive Surgical Oncology, an open-access journal launched at the end of last year, flips the typical narrative — it will pay corresponding authors $500 for every original or review article it accepts. If any author joins the editorial board, the payment — which the journal dubs “royalties” — increases to $600.
Editor Wenyuan Chen admitted it’s an unusual policy: